Amazon is likely to make a “more meaningful move” into U.S. pharmacies over the next six to 12 months, targeting Prime customers willing to pay cash for generic drugs -- likely the uninsured or those with high deductibles, Cleveland Research analyst Rob Eich wrote in a note to clients.
- Eich is also hearing AMZN is looking at tele- and self-service pharmacies “along with leveraging their lockers as potential dispensing options,” and exploring “fringe markets like discount cards, correctional facilities, LTC, and nursing homes”
- Meanwhile some form of HHS proposed rules on drug rebates is likely going through next year which ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.